Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24346596 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
Conditions: Diphtheria;   Pertussis;   Polio;   Hepatitis B;   Tetanus
Intervention: Biological: Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC

Indicates status has not been verified in more than two years